| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HCA | Common Stock | Options Exercise | $576,839 | +12,025 | +27% | $47.97* | 56,097 | 10 Nov 2023 | Direct | F1 |
| transaction | HCA | Common Stock | Tax liability | $1,452,098 | -6,237 | -11% | $232.82 | 49,860 | 10 Nov 2023 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HCA | Stock Appreciation Right | Options Exercise | $0 | -6,500 | -100% | $0.000000* | 0 | 10 Nov 2023 | Common Stock | 6,500 | $47.97 | Direct | F2 |
| transaction | HCA | Stock Appreciation Right | Options Exercise | $0 | -5,525 | -100% | $0.000000* | 0 | 10 Nov 2023 | Common Stock | 5,525 | $47.97 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | Includes 2,283.4544 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. |
| F2 | The stock appreciation rights vested in four equal annual installments beginning on February 5, 2015. |
| F3 | The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets. |